diabetes 6 , renal failure or immunocompromised patients. The prevalence of onychomycosis seems to differ in different studies across the world due to common factors. Patients do not seek treatment because the disease is often minimal or patients are embarrassed to seek medical advice unless the condition becomes serious affecting the quality of life. It was generally accepted that the overall prevalence of onychomycosis was estimated to be between 3 and 5%, but somewhat higher in certain occupational communities and in patients over 40 years of age 4, 7, 8 .
An epidemiological survey was made of 10,000 outpatients who attended dermatology clinics in Thailand regardless of their type of skin diseases. Diseases were examined and confirmed by mycological diagnosis fof fungal infections. The percentage of isolated nondermatophyte pathogens was much higher than previously reported in European surveys. 9 Results in this study showed that more than half of the patients who were clinically compatible with tinea pedis or onychomycosis had nondermatophyte infections Fig. 1, 2 . Scytalidium dimidiatum and Fusarium spp. were the only nondermatophytes isolated in the study, in contrast to European surveys in which Aspergillus spp. and Scopulariopsis brevicaulis were isolated. Only 2.6% had yeast infection by which Candida albicans was the predominant pathogen.
Our data showed a 37.1% prevalence of foot abnormalities among patients who visited the hospital regardless of their skin problems. Among non fungal foot infections, eczema was the leading cause in 40.8% of the patients, followed by 28.3% psoriasis and 10.3% metatarsal corns. The prevalence of fungal foot infections was 6% in which the prevalence of tinea pedis was 2.2 fold than that of onychomycosis.
Non-dermatophyte infection by S. dimidiatum was the leading cause of fungal foot diseases in this epidemiology survey in contrast to similar studies in which dermatophytes were the predominant pathogens 10, 11, 12, 13 . The pan-European surveys showed higher prevalence of dermatophytes, Trichophyton rubrum 53.3% and T. mentagrophytes 12.9% , as major pathogens for onychomycosis in those with fungal foot infection. The prevalence of mold and yeast infections was comparable approximately 10% with Aspergillus spp., S. brevicaulis and C. albicans being the major pathogens 9 .
S. dimidiatum Hendersonula toruloidea, Nattrassia mangiferae is a recognised pathogen of fruit trees in the tropics. It can cause a chronic disease of the soles, toe spaces, palms and nails which is indistinguishable from that of infection by dermatophytes. At least 4 cases of vesicular type tinea pedis, previously believed to be absent in Scytalidium infection 14 , have been established in our series of patients unpublished report . Higher prevalence in Asia may be due to geographical distribution and climate. Discoloration, onycholysis with thickening of the infected nail plates may be present. However, recent study from the Institute of Dermatology, Thailand, showed a predominance of toenail infection with only distal and lateral nail involvement. No other types of onychomycosis, i.e. proximal or superficial white, were seen in the study. Direct examination showed hyphae that varied in width and double-contoured appearance Fig.  3 . Culture must be prepared on a medium without cycloheximide in order to isolate the fungus, although duplicate plates with and without the antibiotics are preferable, as combined infection with dermatophytes can occur. This epidemiological survey indicates that S. dimidiatum is the leading pathogen for tinea pedis and onychomycosis. The study demonstrated a higher prevalence of S. dimidiatum than previously reported dermatophyte infection. Direct examination alone can be misleading since treatment with presently available antifungal preparations is still less than satisfactory. S. dimidiatum may be one of the causes of treatment failure in fungal foot and nail infections unless diagnosis is confirmed by mycological examination. No single drug has been reported to treat all cases of Scytalidium infection with reproducible results. A combination of chemical or surgical nail avulsion of infected nails and continued with a systemic antifungal may be a reasonable treatment option 15 . Precautions for factors such as diabetes, peripheral vascular diseases and occlusive footwear may predispose patients to fungal foot diseases. Increased awareness is necessary to diagnose patients who have lived in or visited endemic areas since migration of untreated cases may cause possible spread in a similar manner to other dermatophyte infections.
Microsporum spp. tinea capitis
Tinea capitis is one of the most common fungal infections in children. Infection by anthropophilic species may result in a spread among close contacts. M. canis is the most common causative agent of tinea capitis in Thailand in about a third of patients, although occasionally M. ferrugineum may cause outbreaks in overcrowded communities. T. tonsurans and T. mentagrophytes are the next common pathogens, each found in approximately 15-20%. The duration of therapy using continuous terbinafine therapy for tinea capitis due to Trichophyton spp. has generally been 4 to 6 weeks, although more recent studies suggest that in some cases shorter duration of 1 or 2 weeks may be sufficient 16 18 . The duration and effectiveness of treatment with various systemic antifungals may in part be dependent upon the causative organism. With M. canis and some ectothrix organisms, the response to treatment may be less compared to tinea capitis due to endothrix organisms 17, 19, 20 . When encountering such organisms, dosage regimen may have to be altered but the appropriate duration of treatment remains to be determined.
Terbinafine pulse therapy has been reported to be effective and safe in the treatment of tinea capitis 21, 22 . However, no standard regimen has been recommended with regard to the number of pulse or dosages administered. A recent study comparing two regimens of 1 standard -dose pulse, and 2 double the standarddose pulse terbinafine given 7 days monthly for 2 consecutive months showed that two pulses of terbinafine were effective in treating most Microsporum spp. infections Fig. 4 23 . Moreover, there was no statistical difference p 0.05 in the cure rates between standard and double-dose pulsed therapy at week 12 60.9% vs. 63.1% or at week 20 82.6% vs. 73.7% , respectively. However, the effective cure rates were significantly higher at week 20 than at week 12 in both groups 82.6% vs. 60.9% and 73.7% vs. 63.1%, respectively , probably reflecting the benefits of sustained tissue concentration and the lipophilic properties of terbinafine. None of the patients had received topical or systemic corticosteroids to reduce inflammation, and in those individuals who had inflammatory tinea capitis, the improvement in clinical score was slower than in patients with non-inflammatory scalp infection. Permanent scarring was noted in one patient who initially had a severe clinical presentation. These findings suggest that kerions may be managed in the same manner as noninflammatory tinea capitis, although appropriate antibiotics should be administered if secondary bacterial infection is present. Clinical severity at the initial pre-treatment appraisal is a major predictive factor for scarring. There was no statistical difference in the failure rate or ineffective cure rate between either groups. Patients who had positive potassium hydroxide staining or organism culture at the end of follow-up were given an additional pulse of terbinafine at the same dose as the first two pulses . All were mycologically cured by the end of 4 weeks after the additional third pulse. Retrospective evaluation showed that patients who subsequently turned out to be treatment failures at week 20 had less than 50% clinical improvement with persistent positive potassium hydroxide staining and organism culture at week 8. Thus, evaluation at this stage may be clinically useful in determining which subjects might need additional therapy in the form of a third pulse. This study has shown that pulsed terbinafine at a higher dosage does not improve the treatment efficacy of tinea capitis caused by Microsporum spp. However, the data clearly demonstrated that the duration of treatment is an important factor in determining the outcome. Two pulses of standard dose terbinafine may be sufficient for treating most cases of Microsporum infection, although additional treatment may be needed if clinical improvement is not evident at week 8 after initiating therapy. In unpublished data, the cure rates of 6 -week continuous griseofulvin were at least comparable to these of pulse terbinafine.
Chromoblastomycosis:
This subcutaneous fungal infection is uncommon with an average annual incidence of 3-5 patients at the Institute of Dermatology, Thailand. The most common pathogen is Fonsecaea pedrosoi. The problem of chromoblastomycosis is its requirement of long treatment duration with specific oral antifungals such as itraconazole or terbinafine. Combined surgical and systemic therapy may improve the disease outcome. An ongoing clinical trial showed that monthly pulses of itraconazole were as effective as a continuous 400 mg/d regimen in the treatment of F. pedrosoi chromoblastomycosis. Preliminary results showed three out of five cases were cured after 12 pulses, 2 cases showed marked improvement at the 12 th month, and 1 case recurred 8 months after treatment was stopped. Squamous cell carcinoma developed on the lesion in one patient who had had chronic chromoblastomycosis for more than 10 years Fig. 5 . If proven effective, this regimen would decrease the cost of treatment by 50%. However, more cases and longer follow-up are required to determine efficacy and relapse rate.
Penicillosis:
Penicillium marneffei is an endemic, opportunistic fungus reported to be prevalent in Southeast Asia. It was first isolated from captive bamboo rats Rhizomys sinensis . Penicillosis is one of the most common opportunistic fungal infections among AIDS patients in Thailand. The first documented human pathogenicity was reported in 1959 that arose from accidental laboratory inoculation 24 , then came successive reports of natural infection in immunocompromised patients 25 27 . A 5-year incidence in northern Thailand in 1991-1996 was more than 1,500 cases.
Penicillosis is uncommon among normal hosts. Most of the affected patients have underlying diseases or immune-compromised states. The most common skin manifestation is molluscum contagiosumlike or umbilicated papules. Diagnosis is by demonstration of intracellular and extracellular basophilic, spherical, oval to elliptical yeast-like 84 Penicillosis is still of major concern among AIDS patients because of high morbidity and mortality. Treatment requires hospitalization or long-term prophylaxis with an expensive systemic oral antifungal which poses a financial burden to patients and the health care system. With the current use of HAART among HIV-infected patients, the incidence of penicillosis, as well as other opportunistic infections, may be declining.
In summary, superficial fungal infections remain a health problem in tropical countries. Subcutaneous mycoses, although uncommon, are a financial burden to patients in terms of treatment and long-term follow up. With AIDS prevalence and geographical endemicity of P. marneffei in Southeast Asia, penicillosis is still a threat, at least to patients who do not get access to proper antiretroviral therapies. With no breakthrough antifungal therapy on the horizon, perhaps new regimens or combination of antifungal drugs may need to be evaluated in well-controlled studies to improve the efficacy of treatment.
